Compares treatment options for Cancer, Breast
Official title FAST-FORWARD vs HAI5
ClinicalTrials.gov ID: NCT06345534
What this study is testing
- What it's testing
- Randomized comparison between the FAST-FORWARD schedule and the HAI5 schedule for breast cancer radiotherapy in 5 fractions.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- histopathological diagnosis of breast cancer
- age 18 years or older
- male or female
- treated with breast conserving surgery or mastectomy with curative intent
- multidisciplinary decision of adjuvant radiotherapy after surgery
You likely can't join if
- distant metastases
- decision of preoperative radiotherapy
- decision of partial breast irradiation
- positive resection margins ('ink on tumour')
- indication for boost on lymph node(s)
- history of thoracic or ipsilateral axillary radiotherapy (including radiotherapy of the contralateral breast or chest wall)
See the full eligibility criteria
- histopathological diagnosis of breast cancer
- age 18 years or older
- male or female
- treated with breast conserving surgery or mastectomy with curative intent
- multidisciplinary decision of adjuvant radiotherapy after surgery
- distant metastases
- decision of preoperative radiotherapy
- decision of partial breast irradiation
- positive resection margins ('ink on tumour')
- indication for boost on lymph node(s)
- history of thoracic or ipsilateral axillary radiotherapy (including radiotherapy of the contralateral breast or chest wall)
- need for bilateral irradiation
- breast reconstruction or expander
- patients unlikely to comply with the protocol (e.g. inability or unwillingness to complete the questionnaires at different time points).
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.